Randomized Phase II Study of Olaparib Maintenance Following Cabazitaxel-Carboplatin Induction Chemotherapy in Men With Aggressive Variant Prostate Cancer (AVPC)
Phase of Trial: Phase II
Latest Information Update: 06 Jan 2018
At a glance
- Drugs Olaparib (Primary) ; Cabazitaxel; Carboplatin; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 03 Oct 2017 Planned primary completion date changed from 27 Mar 2020 to 27 Oct 2020.
- 03 Oct 2017 Planned End Date changed from 1 Mar 2021 to 1 Oct 2021.
- 03 Oct 2017 Status changed from not yet recruiting to recruiting.